Data on adverse events in clinical study reports may not accurately represent underlying patient data, according to two pilot studies in the British Medical Journal, the first from a team lead by Peter Gøtzsche analyzing unredacted clinical study reports and protocols from the European Medicines Association before it closed in 2011. The team is finding that clinical study reports contain extensive data on major harms that are not made available in journal articles and trial registry reports.
Maund, E., Tendal, B., Hróbjartsson, A., Lundh, A., Gøtzsche, P. Coding of adverse events of suicidality in clinical study reports of duloxetine. British Medical Journal. June 4, 2014; 348:g3555. doi: 10.1136/bmj.g3555
Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications. British Medical Journal. June 4, 2014; 348:g3510 doi: 10.1136/bmj.g3510
* * * * *
They will constantly claim there are not big risks associated with this or that psych drug or that these drugs are “safe and effective” while the existing data is biased, incomplete and in big parts unreliable. Clinical trials and drug development should be taken from the hands and funding by pharmaceutical companies.
A lot of people find meditation effective for increased happiness, and its not expensive to learn.